Avalon Investment & Advisory Pfizer Inc Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Avalon Investment & Advisory holds 584,222 shares of PFE stock, worth $16.7 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

584,222

Previous 413,717 41.21%

Holding current value

$16.7 Million

Previous $21.2 Million 12.44%

% of portfolio

0.67%

Previous 0.6%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $6.72 Million - $8.74 Million	170,505 Added 41.21%	584,222 $23.8 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $4.73 Million - $6.18 Million	113,380 Added 37.75%	413,717 $21.2 Million
Q3 2022 Nov 01, 2022	SELL	$43.76 - $53.42 $97,059 - $118,485	-2,218 Reduced 0.73%	300,337 $13.1 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $217,760 - $258,195	4,680 Added 1.57%	302,555 $15.9 Million
Q1 2022 May 17, 2022	SELL	$45.75 - $56.69 $1.68 Million - $2.09 Million	-36,794 Reduced 10.99%	297,875 $15.4 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $3.19 Million - $4.73 Million	-77,220 Reduced 18.75%	334,669 $19.8 Million
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $1.24 Million - $1.59 Million	-31,627 Reduced 7.13%	411,889 $17.7 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $2.49 Million - $2.82 Million	-69,271 Reduced 13.51%	443,516 $17.4 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $1.1 Million - $1.24 Million	-32,856 Reduced 6.02%	512,787 $18.6 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $1.49 Million - $1.89 Million	-44,384 Reduced 7.52%	545,643 $20.1 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $1.02 Million - $1.2 Million	-32,090 Reduced 5.16%	590,027 $21.7 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $4.31 Million - $5.23 Million	-143,229 Reduced 18.71%	622,117 $20.3 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $4.9 Million - $7 Million	-181,351 Reduced 19.16%	765,346 $25 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $2.17 Million - $2.46 Million	-65,849 Reduced 6.5%	946,697 $37.1 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $9.62 Million - $12.5 Million	-296,180 Reduced 22.63%	1,012,546 $36.4 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $1.12 Million - $1.26 Million	-30,410 Reduced 2.27%	1,308,726 $56.7 Million
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $167,137 - $183,628	-4,457 Reduced 0.33%	1,339,136 $56.9 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $732,353 - $834,962	-19,037 Reduced 1.4%	1,343,593 $58.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $8.7 Million - $10.6 Million	-252,497 Reduced 15.63%	1,362,630 $60.1 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $234,322 - $249,811	7,105 Added 0.44%	1,615,127 $58.6 Million
Q1 2018 Jun 26, 2018	SELL	$31.91 - $37.02 $4.69 Million - $5.44 Million	-146,993 Reduced 8.38%	1,608,022 $57.1 Million
Q1 2018 Jun 22, 2018	BUY	$31.91 - $37.02 $2.98 Million - $3.46 Million	93,516 Added 5.63%	1,755,015 $63.6 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $2.98 Million - $3.46 Million	-93,516 Reduced 5.33%	1,661,499 $59 Million
Q4 2017 Jun 22, 2018	SELL	$33.26 - $35.29 $3.32 Million - $3.53 Million	-99,911 Reduced 5.39%	1,755,015 $63.6 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $10.3 Million - $10.9 Million	308,509 Added 19.95%	1,854,926 $67.2 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $3.99 Million - $4.39 Million	128,590 Added 9.07%	1,546,417 $55.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,417,827	1,417,827 $47.6 Million

Others Institutions Holding PFE

# of Institutions

3,231

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Pfizer Inc Transaction History